Journal Article The Function of Music in LSD Therapy for Alcoholic Patients Get access E. Thayer Gaston, E. Thayer Gaston Project Director Search for other works by this author on: Oxford Academic PubMed Google Scholar Charles T. Eagle, Jr. Charles T. Eagle, Jr. Search for other works by this author on: Oxford Academic PubMed Google Scholar Journal of Music Therapy, Volume 7, Issue 1, Spring...
LSD is the only new treatment for alcoholism which has been introduced in recent years; on that basis the authors justify this latest volume on LSD therapy. It gives a very brief, yet scholarly review of the neurophysiological, behavioral, and psychological effects of LSD as well as proposed mechanisms of action, assesses previous therapeutic work with LSD, weighs it in the balance, and finds...
THE PUBLIC has become aware of the increasing use of the major psychedelic substances (lysergic acid diethylamide [LSD], peyote, psilocybin, morning glory seeds) by certain individuals outside the contexts of supervised therapy and research.1,2Several excellent clinical studies have firmly documented the hazards of this Practice.4,5At a time when the scientific community has been gathering...
The author describes his experience with LSD-25 as an adjunct to long-term psychotherapy in 24 patients between September, 1962 and May, 1965, involving a total of 56 LSD-25 sessions for a total duration of 119 1/4 hours. Where therapy blocks developed which could not be overcome, narcoanalysis with or without methylphenidate † was used and if this was not successful LSD-25 was considered. The...
Preliminary results of a study of psychedelic therapy are reported. Patients receive LSD and mescaline in a supportive setting following intensive preparation. Subjective questionnaire data from 113 patients reveal a high frequency of claimed benefit, low frequency of negative reaction, and a high relation between claimed benefit and reported “greater awareness of ultimate reality” through the...
This Special Issue of Neuropharmacology on psychedelics provides a timely and comprehensive update on progress following the previous Neuropharmacology Special Issue “ Psychedelics: New Doors, Altered Perceptions ” . Remarkable advances have been made in basic and clinical research on psychedelics in the five years since 2018. It is partly based on the seminar series focused on psilocybin...
In the last 2 decades, there is a renaissance in the scientific investigation of the therapeutic potential of psychedelic compounds. It is studied for the treatment of many psychiatric disorders, including posttraumatic stress disorder. The treatment is always done in the setting of psychedelic-assisted psychotherapy. A little is known about the potential effects, outside of the setting of...
Jacqueline Samantha Womersley, Gabriela Iacovou, Yumna Kathrada et al.
preprint
Interest in psychedelic treatments for mental health conditions is growing. Health care professionals will be key in the implementation, recommendation, and administration of psychedelic-assisted therapy (PAT) if and when it is approved for clinical use, making their knowledge, attitudes, and perceptions (KAPs) central to successful translation into practice. We conducted a scoping review of...
This essay supports the motion that entrepreneurship research is out of touch with the psychedelic renaissance. It defines this mismatch as selective recognition: the phenomenon encompasses personal transformation, collective practices, and market formation, while scholarly attention foregrounds particular understandings of entrepreneurial benefit. Drawing on an interdisciplinary synthesis, the...
BACKGROUND Suicide is among the top 10 leading causes of death worldwide. Of people who died by suicide, the majority are diagnosed with depression. It is estimated that 25%-60% of people with bipolar depression (BD) will attempt suicide at least once, and 10%-15% will die by suicide. Several treatments, such as lithium, clozapine, electroconvulsive therapy, and cognitive behavioral therapy,...